Streetbeat News

Regulatory

FBLG

FibroBiologics has been granted three Japanese patents related to enhancing fibroblast therapeutic activity, augmenting fibroblasts regenerative activity, and the interaction of fibroblasts and immune cells for activation. These patents, invented by Pete O'Heeron, could significantly advance FibroBiologics' position in regenerative medicine and therapeutic applications.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 2:32 pm

MULN

Mullen Automotive's majority-owned subsidiary, Bollinger Motors, has received approval from the IRS for a $40,000 commercial EV tax credit. This approval could significantly enhance the attractiveness of Bollinger's electric vehicles (EVs) for commercial buyers, potentially boosting sales and impacting Mullen Automotive's financial outlook positively.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 2:23 pm

ZYXI

Zynex, Inc. (NASDAQ:ZYXI) announced FDA clearance for its next-generation M-Wave Neuromuscular Electrical Stimulation device, designed for pain management, rehabilitation, and enhancing exercise performance. The M-Wave, which replaces the E-Wave, offers a more intuitive design and additional functionality, aiming for broader adoption in both clinical and home settings.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 2:16 pm

ZYXI

Zynex, Inc. has received FDA clearance for its M-Wave neuromuscular electrical stimulation device, a significant milestone that could enhance the company's product portfolio and market position.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 2:16 pm

VTRS

The UK's Competition and Markets Authority (CMA) has initiated a merger inquiry into Theramex and Viatris, as reported by Reuters. This investigation will assess the potential impacts of the merger on competition within the UK market.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 2:13 pm

WHR

South Africa's Competition Tribunal has conditionally approved the merger between Beko Europe BV and Whirlpool Corporation's MDA business in Morocco and the UAE. The approval is a significant step towards finalizing the deal, which could have implications for Whirlpool's operations and strategic positioning in these regions.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 2:10 pm

DELL

INTC

LNVGF

Lenovo's shares plummeted nearly 10% following a Newsweek article citing China Tech Threat's advice to ban Lenovo PCs in the U.S. due to espionage risks. This has raised concerns about Lenovo's future in its largest market, North America, which accounts for 36% of its revenue. Additionally, Intel's lower-than-expected revenue forecast has sparked fears of a PC demand slowdown, potentially impacting Lenovo. There's speculation that Dell, a major rival and financial backer of China Tech Threat, might be influencing these developments to harm Lenovo.

Portfolio Pulse from The Bamboo Works

February 06, 2024 | 2:03 pm

DELL

INTC

LNVGF

Lenovo's shares plummeted nearly 10% following a Newsweek article citing China Tech Threat's advice to ban Lenovo PCs in the U.S. due to espionage risks. This has raised concerns about Lenovo's future in its significant North American market, which represents 36% of its revenue. Additionally, Intel's lower-than-expected revenue forecast has sparked fears of a PC demand slowdown, potentially impacting Lenovo. Meanwhile, speculation exists that Dell, a major rival and financial backer of China Tech Threat, might be influencing these developments to harm Lenovo.

Portfolio Pulse from The Bamboo Works

February 06, 2024 | 2:01 pm

AMIX

Autonomix Medical has been granted authorization by an ethics committee for a proof-of-concept human clinical study to evaluate its proprietary ablation technology for treating pancreatic cancer pain. This marks the first study to assess radiofrequency (RF) ablation through a transvascular approach aimed at reducing pain linked to pancreatic cancer. The company is on schedule to begin enrollment for the study in Q1 2024.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 1:52 pm

LAES

SEALSQ Corp (NASDAQ:LAES) announced plans to establish an Open Semiconductors Assembly and Test Center in the US, focusing on semiconductor technology, post-quantum cryptography, and AI. The initiative aims to enhance supply chain resilience and security, supported by the CHIPS Act in the US and the EU Chips Act. The US-based center will integrate quantum-resistant cryptographic capabilities into semiconductor architectures, offering protection against quantum computing threats.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 1:45 pm